Program Evaluation of People With Arthritis Can Exercise

November 16, 2005 updated by: Centers for Disease Control and Prevention

Evaluation of the Health Benefits of the People With Arthritis Can Exercise Program

The purpose of this study is to evaluate the health and arthritis-specific benefits of participation in the Arthritis Foundation People with Arthritis Can Exercise program and to collect information to improve community-based dissemination of this program.

Study Overview

Detailed Description

Only about 24% of people with arthritis report sufficient physical activity to provide general health benefits. Research has demonstrated that many people with arthritis can safely exercise to improve fitness and health. The People with Arthritis Can Exercise (PACE) program, developed by the Arthritis Foundation, is a land-based recreational physical activity and exercise program. PACE has been offered as a community-based program for over 10 years and small studies have reported benefits for people with arthritis. However, there has been no randomized controlled community trials that evaluate the effectiveness of PACE in the community. The goals of the Evaluation of PACE project are to: (1) appropriately evaluate the AF PACE exercise program, and (2) provide information to support effective content, recruitment and programming. Specific objectives for meeting these goals include:

  1. Identify the theoretical foundations and constructs for evaluating the program and select and use appropriate outcome measures;
  2. Plan and conduct a randomized controlled trial of 8 and 16 week PACE programs;
  3. Perform a qualitative evaluation using focus groups of PACE instructors and participants;
  4. Disseminate findings and make recommendations.

Study Type

Interventional

Enrollment

320

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • St. Louis, Missouri, United States, 63104
        • St. Louis University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults age 18 and older
  • Self-reported arthritis or chronic joint symptoms
  • Community-dwelling

Exclusion Criteria:

  • Serious medical conditions which would contraindicate exercise
  • No severe physical or mental condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Physical Activity Level - PASE instrument at baseline, 8 and 16 weeks.
Pain Visual Analog Scale - at baseline, 8 and 16 weeks
Physical Function using the Functional Fitness Battery at baseline, 8 and 16 weeks
Self-reported function (HAQ) at baseline, 8 and 16 weeks

Secondary Outcome Measures

Outcome Measure
Anxiety
Health-related quality of life
Disease status
Self-efficacy for arthritis management
Self-efficacy for exercise
Social support
Depressive symptoms

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jennifer M Hootman, PhD, Centers for Disease Control and Prevention
  • Principal Investigator: Marian Minor, PhD, University of Missouri-Columbia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2003

Study Completion

June 1, 2005

Study Registration Dates

First Submitted

September 7, 2005

First Submitted That Met QC Criteria

September 7, 2005

First Posted (Estimate)

September 12, 2005

Study Record Updates

Last Update Posted (Estimate)

November 17, 2005

Last Update Submitted That Met QC Criteria

November 16, 2005

Last Verified

September 1, 2005

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CDC-NCCDPHP-0507
  • CDC-NCCDPHP-MM-0507

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe